✦ LIBER ✦

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

✍ Scribed by E. Ferrannini; V. Fonseca; B. Zinman; D. Matthews; B. Ahrén; S. Byiers; Q. Shao; S. Dejager

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Efficacy and safety of the dipeptidyl pe

✍ R. E. Pratley; M. S. Kipnes; P. R. Fleck; C. Wilson; Q. Mekki; Alogliptin Study 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Efficacy and safety of vildagliptin and

✍ Y. Iwamoto; A. Kashiwagi; N. Yamada; S. Terao; N. Mimori; M. Suzuki; H. Tachiban 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Nateglinide or gliclazide in combination

✍ S. Ristic; C. Collober-Maugeais; F. Cressier; P. Tang; E. Pecher 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Comparison of vildagliptin and thiazolid

✍ L. Blonde; S. Dagogo-Jack; M. A. Banerji; R. E. Pratley; A. Marcellari; R. Brace 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Safety and efficacy of vildagliptin vers

✍ V. Lukashevich; A. Schweizer; Q. Shao; P.-H. Groop; W. Kothny 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB